Stellantis Q3 Surge Masks European Weakness

What happened

Stellantis shares jumped 13% following third-quarter results, driven by a sharp improvement in North American operations. The North American region rebounded strongly, likely reflecting successful product launches and inventory normalization as outlined in the company's U.S. reinvestment plan. However, Europe moved in the opposite direction, with continued weakness in demand, production, and pricing that offset some of the North American gains. This divergence mirrors the pattern identified in prior analysis: a recovering U.S. business against a structurally challenged European market facing overcapacity and EV price pressure. The market's positive reaction focuses on the U.S. turnaround, but Europe's deterioration remains a significant headwind that could limit overall earnings and cash flow recovery.

Implication

Investors should treat the pop as a reflection of a stronger North American recovery rather than a resolution of Stellantis' structural European problems. The U.S. improvement validates the multi-year capex plan, but the market may be pricing in a clean continuation while European overcapacity and EV discounting still threaten margins. With the stock likely around $12.5 after the surge, it is still below the $13 base-case value and the $14.50 trim level, so the risk-reward is less attractive than at $9 but not yet at a trim trigger. The key question is whether European stabilization materializes; if not, the positive U.S. momentum may not be enough to lift consolidated earnings and free cash flow to justify a higher multiple. Maintain a cautious stance, waiting for evidence that Europe is truly bottoming and that U.S. gains are sustainable without excessive incentives before adding exposure.

Thesis delta

The news strengthens the bull case for North American execution but does not alter the European drag that underpins the WAIT rating. The surge brings the stock closer to the base-case value of $13 but still below the trim level of $14.50, so no change to the rating is warranted yet. Confidence in the U.S. recovery rises modestly, but confidence in European stabilization remains low, keeping the overall conviction unchanged.